Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 411

1.

3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population.

Marrakchi R, Bougatef K, Moussa A, Ouerhani S, Khodjet-el-Khil H, Messai Y, Mestiri O, Najar T, Benammar-Elgaaeid A.

Inflamm Res. 2009 Apr;58(4):218-23. doi: 10.1007/s00011-008-8139-x.

PMID:
19184350
2.

Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.

Dassopoulos T, Frangakis C, Cruz-Correa M, Talor MV, Burek CL, Datta L, Nouvet F, Bayless TM, Brant SR.

Inflamm Bowel Dis. 2007 Feb;13(2):143-51.

PMID:
17206688
3.

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J; Hungarian IBD Study Group, Lakatos PL.

Inflamm Bowel Dis. 2007 Aug;13(8):984-92.

PMID:
17417801
4.

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.

Lakatos PL, Altorjay I, Szamosi T, Palatka K, Vitalis Z, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Barta Z, Stocker W, Papp J, Veres G, Papp M; Hungarian IBD Study Group.

Inflamm Bowel Dis. 2009 Mar;15(3):365-74. doi: 10.1002/ibd.20778.

PMID:
18972554
5.

New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.

Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J; Hungarian IBD Study Group, Lakatos PL.

Am J Gastroenterol. 2008 Mar;103(3):665-81. Epub 2007 Nov 28.

PMID:
18047543
6.

[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].

Lakatos L, Lakatos PL, Willheim-Polli C, Reinisch W, Ferenci P, Tulassay Z, Molnár T, Kovács A, Papp J, Szalay F; Hungarian IBD Study Group.

Orv Hetil. 2004 Jul 4;145(27):1403-11. Hungarian.

PMID:
15320482
7.

Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.

Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J.

Inflamm Bowel Dis. 2004 Sep;10(5):521-8.

PMID:
15472511
8.

Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.

Marrakchi R, Moussa A, Ouerhani S, Bougatef K, Bouhaha R, Messai Y, Rouissi K, Khadimallah I, Khodjet-el-Khil H, Najar T, Benammar-Elgaaeid A.

Inflamm Res. 2009 Mar;58(3):155-60. doi: 10.1007/s00011-008-8265-5.

PMID:
19184348
9.

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.

Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, Satsangi J.

Clin Exp Immunol. 2004 Mar;135(3):490-6.

10.

Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.

Hadrich I, Vandewalle P, Cheikhrouhou F, Makni F, Krichen MS, Sendid B, Standaert-Vitse A, Ayadi A, Poulain D.

Scand J Gastroenterol. 2007 Jun;42(6):717-25.

PMID:
17505994
11.

Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.

Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB.

Eur J Gastroenterol Hepatol. 2007 Mar;19(3):217-23.

PMID:
17301648
12.

Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.

Odes S, Friger M, Vardi H, Claessens G, Bossuyt X, Riis L, Munkholm P, Wolters F, Yona H, Hoie O, Beltrami M, Tsianos E, Katsanos K, Mouzas I, Clofent J, Monteiro E, Messori A, Politi P, O'Morain C, Limonard C, Russel M, Vatn M, Moum B, Stockbrugger R, Vermeire S; European Collaborative Study Group on Inflammatory Bowel disease.

Inflamm Bowel Dis. 2007 Jul;13(7):874-81.

PMID:
17278126
13.

Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.

Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A.

Am J Gastroenterol. 2005 Jan;100(1):84-92.

PMID:
15654786
14.

Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.

Ernst A, Jacobsen B, Østergaard M, Okkels H, Andersen V, Dagiliene E, Pedersen IS, Thorsgaard N, Drewes AM, Krarup HB.

Scand J Gastroenterol. 2007 Dec;42(12):1445-51.

PMID:
17852840
15.

CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.

van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW.

Eur J Gastroenterol Hepatol. 2007 Jun;19(6):449-59. Review.

PMID:
17489054
16.

CARD15 gene polymorphisms in Serbian patients with Crohn's disease: genotype-phenotype analysis.

Protic MB, Pavlovic ST, Bojic DZ, Krstic MN, Radojicic ZA, Tarabar DK, Stevanovic AZ, Karan Djurasevic TZ, Godjevac MV, Svorcan PV, Dapcevic BD, Jojic NZ.

Eur J Gastroenterol Hepatol. 2008 Oct;20(10):978-84. doi: 10.1097/MEG.0b013e328302f45e.

PMID:
18787464
17.

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.

Riis L, Vind I, Vermeire S, Wolters F, Katsanos K, Politi P, Freitas J, Mouzas IA, O'Morain C, Ruiz-Ochoa V, Odes S, Binder V, Munkholm P, Moum B, Stockbrügger R, Langholz E; European Collaborative Study Group on Inflammatory Bowel Disease.

Inflamm Bowel Dis. 2007 Jan;13(1):24-32.

PMID:
17206636
18.

CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status.

Crawford NP, Colliver DW, Eichenberger MR, Funke AA, Kolodko V, Cobbs GA, Petras RE, Galandiuk S.

Dig Dis Sci. 2007 Oct;52(10):2716-24. Epub 2007 Apr 3.

PMID:
17404888
19.

Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.

Büning C, Genschel J, Bühner S, Krüger S, Kling K, Dignass A, Baier P, Bochow B, Ockenga J, Schmidt HH, Lochs H.

Aliment Pharmacol Ther. 2004 May 15;19(10):1073-8.

20.

CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease.

Kugathasan S, Collins N, Maresso K, Hoffmann RG, Stephens M, Werlin SL, Rudolph C, Broeckel U.

Clin Gastroenterol Hepatol. 2004 Nov;2(11):1003-9.

PMID:
15551253
Items per page

Supplemental Content

Write to the Help Desk